Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Donor Stem Cell Transplant in Treating Patients With High Risk Acute Myeloid Leukemia

    ... This phase I trial studies the side effects of donor stem cell transplant in treating patients with high risk acute myeloid ... Patients must be medically ineligible for allogeneic stem cell transplant (alloSCTx) or not have a known fully ...

    Clinical Trial last updated 06/13/2016 - 3:31pm.

  2. Transplantation

     

    Page last updated 01/20/2015 - 4:45pm.

  3. Selective Depletion of CD45RA+ Naive T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD

    ... myelogenous leukemia undergoing donor peripheral blood stem cell transplant . Giving chemotherapy and total-body ... Patients who are considered appropriate candidates for allogeneic hematopoietic stem cell transplantation and have one of the ...

    Clinical Trial last updated 06/06/2016 - 2:55pm.

  4. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS system for T cell depletion plus ...

    Clinical Trial last updated 06/06/2016 - 3:10pm.

  5. Allogeneic Stem Cell Transplant With Alpha/Beta T AND B Cell Depletion for Hematologic Malignancies (AB-CliniMACs)

    ... is a single arm pilot study for patients using α/β T cell -depleted PSCT in with alternative donor sources with hematologic ... or partially matched related) mobilized peripheral stem cells (PSCs) using the CliniMACS system for T cell depletion plus ...

    Clinical Trial last updated 06/03/2016 - 2:45pm.

  6. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... Purpose:  Allogeneic hematopoietic stem cell transplantation (aHSCT) can cure patients with a variety of bone ...

    Clinical Trial last updated 04/28/2016 - 2:40pm.

  7. Maintenance Low Dose 5'-Azacitidine Post T Cell Depleted Allogeneic Stem Cell Transplantation for Patients With Myelodysplastic Syndrome and Acute Myelogenous Leukemia With High Risk for Post-Transplant Relapse

    ... to lower the risk of the disease coming back after a stem cell transplant in patients with MDS and AML. This study will also be ... start taking the study drug between days 60-120 post TCD allogeneic hematopoietic stem cell transplant and up to a year post-transplant ...

    Clinical Trial last updated 04/27/2016 - 1:19pm.

  8. Preventing Stem Cell Transplant Complications With a Blood Separator Machine

    ... Background: - Researchers are working to make stem cell transplant procedures safer and more effective. One complication ... hematologic conditions meeting a standard indication for allogeneic stem cell transplant : 5.1.2.1 Chronic myelogenous leukemia ...

    Clinical Trial last updated 05/23/2016 - 10:57am.

  9. Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    ... Total body irradiation (TBI)-based conditioning prior to allogeneic stem cell transplant . The target patient populations are those with ALL, ...

    Clinical Trial last updated 05/03/2016 - 11:29am.

  10. Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells

    ... Purpose:  Allogeneic hematopoietic stem cell transplantation (aHSCT) can cure patients with a variety of bone ...

    Clinical Trial last updated 04/25/2016 - 10:08am.